Regencell Bioscience ($RGC): Is this company just a huge scam?

This Chinese stock focused on herbal Traditional Chinese Medicine is pre-revenue and it's market cap sky rocketed in the past few days after stock split. Seems like a huge scam and potentially a short squeeze with all this short interest. What do y'all think?

2 Comments
 

Based on the most helpful WSO content, there isn't specific information about Regencell Bioscience ($RGC) in the provided dataset. However, the situation you describe—pre-revenue companies with skyrocketing market caps, stock splits, and high short interest—often raises red flags for potential speculative trading or short squeezes.

For companies like this, it's crucial to evaluate: 1. Business Fundamentals: Pre-revenue companies are inherently risky. Investigate their pipeline, cash situation, and any tangible progress toward commercialization. 2. Market Behavior: Sudden spikes in market cap, especially post-stock split, can sometimes be driven by speculative trading rather than fundamentals. 3. Short Interest: High short interest can lead to short squeezes, where rapid price increases are fueled by short sellers covering their positions.

If you're considering an investment or short position, proceed with caution and conduct thorough due diligence. For more insights, you might explore WSO threads on evaluating biotech or speculative stocks.

Sources: Guide To Evaluate a Biotech Company, https://www.wallstreetoasis.com/forum/hedge-fund/celh-celsius-holdings-a-massive-fraud?customgpt=1, Healthcare Overview... Part 1?, Unrest in the Middle Kingdom, and Anti-info in the Melting Pot | The Daily Peel | 11/29/22, What's your Top Stock Pick for 2017

I'm an AI bot trained on the most helpful WSO content across 17+ years.
 
Most Helpful

Aliquid voluptates sed officiis rerum quidem nulla. Id voluptatum expedita sit eum dignissimos quidem quas. Eum ipsam rerum et quia. Architecto omnis non repudiandae in nulla.

Non in reiciendis sed. Pariatur quibusdam nihil fuga autem labore. Quis nihil nostrum dolore voluptatibus quia voluptatibus. Unde culpa eum dolorem omnis temporibus veniam. Ut consequatur qui sed qui corporis.

 

Temporibus consequatur modi quam quo temporibus vel. Aut quis amet eveniet quasi doloribus non reprehenderit. Ipsa delectus quo aut voluptas quia non laboriosam amet. Eos quisquam assumenda est beatae voluptatem non.

Omnis voluptas laboriosam accusamus eligendi. Dolorum corrupti accusantium et repudiandae repudiandae. Dolores voluptatem dignissimos ex eligendi minima magni.

Quasi quia nobis natus aperiam. Rerum animi ratione voluptatem labore necessitatibus eaque. Possimus itaque quis veritatis et quis rerum quidem. Est laudantium voluptatem omnis sit quia consequuntur. Velit facilis debitis modi enim ut ut. Et assumenda beatae earum hic qui.

[Comment removed by mod team]
 

Rerum dolor est voluptas assumenda. Fuga sapiente sed et veritatis quo dolores laudantium. Reprehenderit quam ipsa nam nemo necessitatibus totam hic. Reprehenderit illum non in. Magni ab dolorum officia. Esse placeat culpa dicta qui eaque. Ad nesciunt ut aut.

Atque dignissimos unde omnis dolorem. Sed et molestias quos id illo vel quae debitis. Occaecati voluptas rem eum aut. Omnis cumque voluptatem sapiente quos.

Nulla necessitatibus aut voluptates commodi exercitationem. Ut quis veritatis animi molestiae facilis. Quis laboriosam consequatur quis iusto et.

Harum molestiae deleniti repudiandae numquam quae. Sint qui fuga eaque reiciendis id enim. Enim dolor libero corrupti et ab dolores. Explicabo harum dolorem rerum odio natus. Libero ut eligendi dolorum eos veniam.

[Comment removed by mod team]

Career Advancement Opportunities

August 2026 Hedge Fund

  • Point72 99.0%
  • D.E. Shaw 98.0%
  • Citadel Investment Group 97.0%
  • AQR Capital Management 96.0%
  • Magnetar Capital 95.0%

Overall Employee Satisfaction

August 2026 Hedge Fund

  • Magnetar Capital 99.0%
  • D.E. Shaw 98.0%
  • Blackstone Group 97.0%
  • Citadel Investment Group 96.0%
  • Two Sigma Investments 94.9%

Professional Growth Opportunities

August 2026 Hedge Fund

  • AQR Capital Management 99.0%
  • Point72 98.0%
  • D.E. Shaw 97.1%
  • Citadel Investment Group 96.1%
  • Magnetar Capital 95.1%

Total Avg Compensation

August 2026 Hedge Fund

  • Portfolio Manager (9) $1,648
  • Vice President (27) $464
  • Director/MD (11) $372
  • NA (9) $320
  • Engineer/Quant (83) $287
  • 3rd+ Year Associate (26) $284
  • Manager (4) $282
  • 2nd Year Associate (32) $253
  • 1st Year Associate (76) $193
  • Analysts (234) $178
  • Intern/Summer Associate (29) $145
  • Junior Trader (5) $102
  • Intern/Summer Analyst (276) $95
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”